Better Therapeutics (BTTX) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Better Therapeutics Short Interest DataBetter Therapeutics (BTTX) has a short interest of 1,000 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 16,426 shares to cover all short positions.Current Short Interest1,000 sharesPrevious Short Interest1,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.10Short Interest Ratio0.0 Days to CoverLast Record DateJune 30, 2025Outstanding Shares49,862,000 sharesShort Percent of Float0.00%Today's Trading Volume0 sharesAverage Trading Volume16,426 sharesToday's Volume Vs. Average0% Short Selling Better Therapeutics? Sign up to receive the latest short interest report for Better Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBTTX Short Interest Over TimeBTTX Days to Cover Over TimeBTTX Percentage of Float Shorted Over Time Better Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20251,000 shares $0.10 No Change0.0%0 $0.00 6/15/20251,000 shares $0.00 No Change0.0%0 $0.00 5/31/20251,000 shares $0.10 No Change0.0%0.2 $0.00 5/15/20251,000 shares $0.20 No ChangeN/A0 $0.00 4/30/20251,000 shares $0.20 No ChangeN/A0.3 $0.00 4/15/20251,000 shares $0.10 No ChangeN/A0.1 $0.00 3/14/20251,000 shares $0.20 No ChangeN/A0.1 $0.00 2/28/20251,000 shares $0.20 No ChangeN/A0 $0.00 2/14/20251,000 shares $0.00 No ChangeN/A0 $0.00 1/31/20251,000 shares $0.00 No ChangeN/A5 $0.00 Get the Latest News and Ratings for BTTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Better Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20251,000 shares $0.00 No ChangeN/A10 $0.00 3/15/20242,560,000 shares $114.18 thousand +20.2%8.3%0.4 $0.04 2/29/20242,130,000 shares $338.03 thousand +7.0%7.4%0.9 $0.16 2/15/20241,990,000 shares $405.96 thousand +107.1%6.9%1 $0.20 1/31/2024960,700 shares $181.76 thousand -29.9%3.4%0.5 $0.19 1/15/20241,370,000 shares $319.62 thousand +20.2%5.7%0.8 $0.23 12/31/20231,140,000 shares $222.30 thousand -38.0%4.5%0.4 $0.20 12/15/20231,840,000 shares $461.84 thousand -39.1%7.6%0.9 $0.25 11/30/20233,020,000 shares $591.62 thousand -2.3%13.0%1.5 $0.20 11/15/20233,090,000 shares $501.51 thousand +94.3%13.3%1.7 $0.16 10/31/20231,590,000 shares $227.05 thousand +117.5%8.3%1 $0.14 10/15/2023731,200 shares $229.45 thousand +201.8%4.4%0.5 $0.31 9/30/2023242,300 shares $88.68 thousand +6.7%1.2%0.3 $0.37 9/15/2023227,100 shares $113.66 thousand -14.9%1.1%0.3 $0.50 8/31/2023267,000 shares $165.57 thousand -6.7%1.3%0.3 $0.62 8/15/2023286,200 shares $189.21 thousand +79.0%1.4%0.3 $0.66 7/31/2023159,900 shares $119.37 thousand -68.1%1.0%0.2 $0.75 7/15/2023500,500 shares $425.53 thousand +752.6%4.9%0.6 $0.85 6/30/202358,700 shares $63.40 thousand +7.1%0.6%0.1 $1.08 6/15/202354,800 shares $53.70 thousand -38.3%0.5%0.3 $0.98 5/31/202388,800 shares $62.17 thousand -42.6%2.8%0.6 $0.70 5/15/2023154,600 shares $121.07 thousand +19.1%4.8%1.2 $0.78 4/30/2023129,800 shares $151.22 thousand -30.3%6.7%1.2 $1.17 4/15/2023186,200 shares $245.78 thousand +51.4%8.1%2.4 $1.32 3/31/2023123,000 shares $86.10 thousand +21.3%1.5%2.1 $0.70 3/15/2023101,400 shares $94.30 thousand +18.0%1.2%3.4 $0.93 2/28/202385,900 shares $103.08 thousand -21.5%1.1%3 $1.20 2/15/2023109,400 shares $132.38 thousand +2.7%1.4%3.9 $1.21 1/31/2023106,500 shares $145.91 thousand -30.7%1.4%3.3 $1.37 1/15/2023153,600 shares $211.97 thousand +6.6%2.0%4.1 $1.38Altucher: Trump’s Great Gain is starting (Ad)New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.See Altucher’s Trump crypto prediction here 12/30/2022144,100 shares $159.23 thousand +17.4%1.9%3.6 $1.11 12/15/2022122,800 shares $171.92 thousand +20.6%1.6%2.9 $1.40 11/30/2022101,800 shares $148.63 thousand +39.8%1.3%1.5 $1.46 11/15/202272,800 shares $104.83 thousand -38.2%1.0%0.9 $1.44 10/31/2022117,700 shares $182.44 thousand +22.6%1.5%0.9 $1.55 10/15/202296,000 shares $149.76 thousand +15.3%1.3%0.1 $1.56 9/30/202283,300 shares $146.61 thousand -15.1%1.1%0.1 $1.76 9/15/202298,100 shares $201.11 thousand -58.4%1.3%0.1 $2.05 8/31/2022235,600 shares $402.88 thousand +161.5%3.0%0.2 $1.71 8/15/202290,100 shares $163.08 thousand +55.3%1.2%0 $1.81 7/31/202258,000 shares $128.76 thousand -74.3%0.8%0 $2.22 7/15/2022225,400 shares $376.42 thousand -35.8%2.9%0 $1.67 6/30/2022351,100 shares $547.72 thousand +2.2%4.6%0.1 $1.56 6/15/2022343,700 shares $501.80 thousand -66.0%4.5%0.1 $1.46 5/31/20221,010,000 shares $1.83 million -46.0%13.0%0.2 $1.81 5/15/20221,870,000 shares $3.25 million +1,885.1%24.0%0.3 $1.74 4/30/202294,200 shares $85.91 thousand +73.8%1.2%0 $0.91 4/15/202254,200 shares $76.42 thousand +54.9%0.7%0.3 $1.41 3/31/202235,000 shares $69.30 thousand -82.4%0.5%0.3 $1.98 3/15/2022198,500 shares $619.32 thousand +0.5%2.5%1.8 $3.12 2/28/2022197,500 shares $564.85 thousand -12.4%2.5%1.8 $2.86 2/15/2022225,400 shares $852.01 thousand +6.0%2.9%0.6 $3.78 1/31/2022212,700 shares $821.02 thousand -1.1%2.4%0.5 $3.86 1/15/2022215,100 shares $989.46 thousand -19.5%2.5%0.1 $4.60 12/31/2021267,200 shares $1.24 million No Change3.1%0.1 $4.65 BTTX Short Interest - Frequently Asked Questions What is Better Therapeutics' current short interest? Short interest is the volume of Better Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 1,000 shares of BTTX short. 0.00% of Better Therapeutics' shares are currently sold short. Learn More on Better Therapeutics' current short interest. What is a good short interest percentage for Better Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Better Therapeutics' floating shares are currently sold short. How does Better Therapeutics' short interest compare to its competitors? 0.00% of Better Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Better Therapeutics: UpHealth, Inc. (0.07%), Natera, Inc. (5.03%), Hims & Hers Health, Inc. (35.39%), Guardant Health, Inc. (8.05%), Option Care Health, Inc. (2.73%), RadNet, Inc. (9.33%), BrightSpring Health Services, Inc. (17.22%), Sotera Health Company (8.39%), Surgery Partners, Inc. (15.07%), Privia Health Group, Inc. (3.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Better Therapeutics stock? Short selling BTTX is an investing strategy that aims to generate trading profit from Better Therapeutics as its price is falling. BTTX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Better Therapeutics? A short squeeze for Better Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BTTX, which in turn drives the price of the stock up even further. How often is Better Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTTX, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies UpHealth Short Interest American Oncology Network Short Interest LifeMD Short Interest P3 Health Partners Short Interest Talkspace Short Interest Oncology Institute Short Interest Natera Short Interest Fresenius Medical Care AG & Co. KGaA Short Interest Hims & Hers Health Short Interest Guardant Health Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BTTX) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
